The second research area is immunotherapy, led by iFIT co-founder Hans-Georg Rammensee, who researches personalized peptide vaccines for cancer patients. The cluster also develops bispecific ...
Clinical Trials Arena on MSN15d
PDS Biotechnology commences trial for head and neck squamous cell carcinomaPDS Biotechnology has commenced the randomised, multi-centre Phase III clinical trial, VERSATILE-003, to assess the efficacy and safety of Versamune HPV plus pembrolizumab for head and neck squamous ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback